These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6814776)

  • 1. Recent developments in the field of Chagas' disease.
    Brener Z
    Bull World Health Organ; 1982; 60(4):463-73. PubMed ID: 6814776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenge of Chagas' disease: has the human pathogen, Trypanosoma cruzi, learned how to modulate signaling events to subvert host cells?
    Lima FM; Oliveira P; Mortara RA; Silveira JF; Bahia D
    N Biotechnol; 2010 Dec; 27(6):837-43. PubMed ID: 20172059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parasite persistence correlates with disease severity and localization in chronic Chagas' disease.
    Zhang L; Tarleton RL
    J Infect Dis; 1999 Aug; 180(2):480-6. PubMed ID: 10395865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma cruzi infection by oral route: how the interplay between parasite and host components modulates infectivity.
    Yoshida N
    Parasitol Int; 2008 Jun; 57(2):105-9. PubMed ID: 18234547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunology of experimental Chagas' disease. IV. Production of lesions in rabbits similar to those of chronic Chagas' disease in man.
    Teixeira AR; Teixeira ML; Santos-Buch CA
    Am J Pathol; 1975 Jul; 80(1):163-80. PubMed ID: 808136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
    Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
    Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction with host factors exacerbates Trypanosoma cruzi cell invasion capacity upon oral infection.
    Covarrubias C; Cortez M; Ferreira D; Yoshida N
    Int J Parasitol; 2007 Dec; 37(14):1609-16. PubMed ID: 17640647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incrimination of Eratyrus cuspidatus (Stal) in the transmission of Chagas' disease by molecular epidemiology analysis of Trypanosoma cruzi isolates from a geographically restricted area in the north of Colombia.
    Dib J; Barnabe C; Tibayrenc M; Triana O
    Acta Trop; 2009 Sep; 111(3):237-42. PubMed ID: 19442641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of neural cell adhesion molecule in Chagas' myocarditis.
    Soler AP; Gilliard G; Xiong Y; Knudsen KA; Martin JL; De Suarez CB; Mota Gamboa JD; Mosca W; Zoppi LB
    Hum Pathol; 2001 Feb; 32(2):149-55. PubMed ID: 11230701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American trypanosomiasis (Chagas' disease) in the Caribbean.
    Petana WB
    Bull Pan Am Health Organ; 1978; 12(1):45-50. PubMed ID: 96895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic and proteomic approaches for Chagas' disease: critical analysis of diagnostic methods.
    Huete-Pérez JA; Flores-Obando RE; Ghedin E; Caffrey CR
    Expert Rev Mol Diagn; 2005 Jul; 5(4):521-30. PubMed ID: 16013970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indeterminate Chagas' disease: Trypanosoma cruzi strain and re-infection are factors involved in the progression of cardiopathy.
    Bustamante JM; Rivarola HW; Fernández AR; Enders JE; Fretes R; Palma JA; Paglini-Oliva PA
    Clin Sci (Lond); 2003 Apr; 104(4):415-20. PubMed ID: 12653687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inconclusive results in conventional serological screening for Chagas' disease in blood banks: evaluation of cellular and humoral response.
    Furuchó CR; Umezawa ES; Almeida I; Freitas VL; Bezerra R; Nunes EV; Sanches MC; Guastini CM; Teixeira AR; Shikanai-Yasuda MA
    Trop Med Int Health; 2008 Dec; 13(12):1527-33. PubMed ID: 18983272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pragmatic data and observations related to the epidemiology of Chagas disease].
    Schenone H; Rojas A
    Bol Chil Parasitol; 1989; 44(3-4):66-86. PubMed ID: 2518649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of cases of leishmaniasis in the Province of Salta: evidences of mixed infection with Trypanosoma cruzi and Leishmania spp].
    Chiaramonte MG; Zwirner NW; Caropresi SL; Heredia V; Taranto NJ; Malchiodi EL
    Medicina (B Aires); 1996; 56(3):259-68. PubMed ID: 9035482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophages in experimental Chagas' disease.
    Kuhn RE
    Immunol Ser; 1994; 60():495-502. PubMed ID: 8251589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A three-dimensional multi-agent-based model for the evolution of Chagas' disease.
    Galvão V; Miranda JG
    Biosystems; 2010 Jun; 100(3):225-30. PubMed ID: 20347006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chagas' disease: trends in immunological research and prospects for immunoprophylaxis.
    Teixeira AR
    Bull World Health Organ; 1979; 57(5):697-710. PubMed ID: 120233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Crotalus viridis viridis snake venom on the ultrastructure and intracellular survival of Trypanosoma cruzi.
    Adade CM; Cons BL; Melo PA; Souto-Padrón T
    Parasitology; 2011 Jan; 138(1):46-58. PubMed ID: 20663246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.